Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RCCD1 and UNC45A antisense RNA 1 (RCCD1-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense orientation at the RCCD1 and UNC45A locus. While antisense RNAs in general are recognized for their roles in regulating gene expression through mechanisms such as transcriptional interference, epigenetic modulation, and modulation of splicing, there is currently no direct evidence that RCCD1-AS1 itself serves as a therapeutic target or is involved in well-defined biological processes or diseases. Its precise function remains uncharacterized in the literature, but, as with similar lncRNAs, it may impact the expression of its neighboring protein-coding genes or act through RNA–chromatin interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RCCD1 and UNC45A antisense RNA 1 (RCCD1-AS1).